VOYA Investment Management
RLAY icon

VOYA Investment Management’s Relay Therapeutics RLAY Stock Holding History

VOYA Investment Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.47M Buy
238,836
+22,784
+11% +$331K ﹤0.01% 915
2026
Q1 		$2.15M Buy
216,052
+191,477
+779% +$1.71M ﹤0.01% 1145
2025
Q4 		$208K Hold
24,575
– – ﹤0.01% 2137
2025
Q3 		$128K Sell
24,575
-11,791
-32% -$45K ﹤0.01% 2263
2025
Q2 		$126K Buy
36,366
+2,331
+7% +$6.93K ﹤0.01% 2434
2025
Q1 		$89.2K Sell
34,035
-127,792
-79% -$501K ﹤0.01% 2458
2024
Q4 		$667K Buy
161,827
+128,934
+392% +$702K ﹤0.01% 1807
2024
Q3 		$233K Sell
32,893
-441
-1% -$3.29K ﹤0.01% 2407
2024
Q2 		$217K Buy
33,334
+3,283
+11% +$22.4K ﹤0.01% 2423
2024
Q1 		$249K Sell
30,051
-7,496
-20% -$73.1K ﹤0.01% 2348
2023
Q4 		$413K Sell
37,547
-97,589
-72% -$823K ﹤0.01% 2171
2023
Q3 		$1.14M Buy
135,136
+58,411
+76% +$628K ﹤0.01% 1564
2023
Q2 		$964K Sell
76,725
-25,451
-25% -$317K ﹤0.01% 1689
2023
Q1 		$1.68M Hold
102,176
– – ﹤0.01% 1425
2022
Q4 		$1.53M Buy
102,176
+3,214
+3% +$61.5K ﹤0.01% 1445
2022
Q3 		$2.21M Buy
98,962
+70,190
+244% +$1.54M ﹤0.01% 1286
2022
Q2 		$482K Buy
28,772
+2,152
+8% +$46.1K ﹤0.01% 1855
2022
Q1 		$797K Buy
26,620
+1,833
+7% +$44.5K ﹤0.01% 1626
2021
Q4 		$761K Buy
24,787
+1,866
+8% +$59K ﹤0.01% 1730
2021
Q3 		$723K Hold
22,921
– – ﹤0.01% 1807
2021
Q2 		$839K Buy
22,921
+3,076
+16% +$101K ﹤0.01% 1765
2021
Q1 		$686K Buy
19,845
+5,849
+42% +$254K ﹤0.01% 1836
2020
Q4 		$582K Buy
13,996
+3,779
+37% +$171K ﹤0.01% 1823
2020
Q3 		$435K Buy
+10,217
New +$390K ﹤0.01% 1747

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

VOYA Investment Management's RLAY Position: Q2 2026 in Review

VOYA Investment Management increased its Relay Therapeutics (RLAY) stake by 11% in Q2 2026, buying an estimated $331K and bringing the position to 238,836 shares worth $4.47M. The position accounts for ﹤0.01% of the portfolio, ranked #915.

VOYA Investment Management first reported a position in RLAY in Q3 2020 and has held it in 24 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • VOYA Investment Management held 238,836 shares of Relay Therapeutics worth $4.47M as of Q2 2026.
  • VOYA Investment Management bought 22,784 Relay Therapeutics shares in Q2 2026, an estimated $331K.
  • Relay Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #915 holding.
  • VOYA Investment Management first reported a position in Relay Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.